Skip to main content
. 2013 Jan 11;76(3):475–483. doi: 10.1111/bcp.12078

Figure 2.

Figure 2

Individual indinavir (A) AUC(0,12 h) and (B) C12 h for HIV-infected pregnant women using 400/100 mg twice daily during the second and third trimesters of pregnancy and post-partum. Dashed line represents (A) the 10th percentile AUC (12.9 μg ml−1 h) in non-pregnant historical patients and (B) suggested minimum target trough concentration (0.1 μg ml−1)